tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Income Statement

Compare
804 Followers

Gyre Therapeutics Income Statement

Last quarter (Q4 2024), Gyre Therapeutics's total revenue was $27.87M, a decrease of -7.04% from the same quarter last year. In Q4, Gyre Therapeutics's net income was $12.47M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 105.76M$ 113.45M$ 794.00K$ 7.34M$ 20.95M
Gross Profit
$ 101.87M$ 108.81M$ -4.00K$ -42.00K$ 11.79M
Operating Expenses
$ 85.71M$ 176.04M$ 30.40M$ 87.85M$ 69.16M
Depreciation and Amortization
$ 0.00$ 1.11M$ 1.13M$ 290.00K$ 138.00K
EBITDA
$ 16.16M$ 20.33M$ 10.33M$ -87.60M$ -57.37M
Operating Income
$ 16.16M$ -67.23M$ -8.61M$ -87.89M$ -57.37M
Other Income/Expenses
$ 7.05M$ -9.73M$ 209.00K$ -39.00K$ 1.13M
Pretax Income
$ 23.22M$ -76.97M$ -7.89M$ -87.93M$ -56.24M
Net Income
$ 12.09M$ -92.93M$ 2.30M$ -87.93M$ -55.54M
Per Share Metrics
Basic EPS
$ 0.34$ -1.41$ 0.04$ -2.87$ -2.90
Diluted EPS
$ 0.28$ -1.41$ 0.03$ -2.87$ -2.90
Weighted Average Shares Outstanding
85.09M 65.83M 76.74M 30.64M 19.18M
Weighted Average Shares Outstanding (Diluted)
102.29M 65.83M 75.69M 30.64M 19.18M
Currency in USD

Gyre Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis